Cited by 62Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid Metabolism

Lipid and Apolipoprotein Predictors of Atherosclerosis in Youth: Apolipoprotein Concentrations Do Not Materially Improve Prediction of Arterial Lesions in PDAY Subjects

Rainwater, David L., McMahan, C. Alex, Malcom, Gray T., Scheer, W. Douglas, Roheim, Paul S., McGill, Henry C., Strong, Jack P.·1999·Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Abstract —We compared serum lipid and apolipoprotein predictors of atherosclerosis in cases from the multicenter study, Pathobiological Determinants of Atherosclerosis in Youth (PDAY). The lipid measures included HDL cholesterol (HDL-C) and non-HDL-C, and the apolipoprotein measures included concentrations of apoA1, apoB, and Lp(a), and sizes of the apo(a) proteins. We tested whether the apolipoprotein measures predicted atherosclerotic lesions as well as the more traditional lipid measures. We estimated extent of lesions as fatty streaks or raised lesions (fibrous plaques, complicated or calcified lesions) in 3 sites: thoracic aorta, abdominal aorta, and right coronary artery. Neither apoA1 nor apoB measures were as strongly or consistently correlated with extent of lesions as the corresponding lipid measure (HDL-C and non-HDL-C, respectively). Beyond the basic model that included sex, age, race, smoking status, hypertension, and the lipid measures, apoA1 and apoB added only an average 1.3% increased explanatory ability to the model, whereas HDL-C plus non-HDL-C added an average 2.5%. The results suggest that the traditional lipid measures are more useful than apolipoprotein measures for detecting young persons at high risk of precocious atherosclerosis. Because of large racial differences, the two Lp(a)-related measures, Lp(a) concentrations and apo(a) size, were evaluated in blacks and whites separately. Under these circumstances, neither of the Lp(a)-related measures was strongly or consistently correlated with extent of lesions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.19.3.753

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The value of non-HDL-C in CVD risk assessment was first proposed by Frost and Havel in 1998, and this relationship has now been confirmed in many studies.

    “The value of non-HDL-C in CVD risk assessment was first proposed by Frost and Havel in 1998, 61 and this relationship has now been confirmed in many studies. [203]3][204][205][206][207][208][209][210][211][212][213][214][215][216]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rainwater, D. L., McMahan, C. A., Malcom, G. T., Scheer, W. D., Roheim, P. S., McGill, H. C., & Strong, J. P.
Affiliations
Louisiana State University (US)
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
1999-03
Volume
19
Issue
3
Pages
753-761
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W1996283851
Cited by
62
References
2
Citations by year
2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 3 · 2013: 8 · 2012: 6
FWCI
1.73
Type
journal article
Language
en
Open access
closed
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r10hl033750-05, 5r10hl033733-03, 5r10hl033765-03)
  • National Heart, Lung, and Blood Institute (HL 33750, HL 33733, HL33765)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
atherosclerosis, youth, apolipoprotein A-I, apolipoprotein B, lipoprotein(a), HDL cholesterol, non-HDL cholesterol, fatty streaks, coronary artery lesions, aortic lesions, racial differences, cardiovascular risk prediction
MeSH terms
Adolescent, Adult, Aorta, Apolipoproteins A, Apolipoproteins B, Arteriosclerosis, Endothelium, Vascular, Female, Humans, Hypertension, Cholesterol, HDL, Male, Predictive Value of Tests, Risk Factors, Smoking, Lipoprotein(a), Age Distribution, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review